bioaccess® is the clinical research CRO in Costa Rica for first-in-human device work: Miami headquarters, in-country operations, and the CONIS/CEC file — accredited ethics, CONIS registration, the 3% canon, and ~30–90 day approval. We run trials there.
bioaccess® is the CRO in Costa Rica and CRO en Costa Rica for first-in-human device work. Miami headquarters. CONIS (Consejo Nacional de Investigación en Salud), an organ of the Ministry of Health, and the accredited Comité Ético Científico (CEC) network are the authorities on the file. The CRO on the file treats the two gates — CEC written approval, then CONIS registration — as one timeline.